Cravath Swaine & Moore 01/fa
EDGAR Filing Agent Form List
CIK: 0000950157
Form Type:
Year
| Form | Filer/Owner | Description | Subject Company | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13D/A | Biogen Inc. | 05/14/2026 | |||
| SCHEDULE 13D/A | Apellis Pharmaceuticals, Inc. | 05/14/2026 | |||
| S-8 | Cable One, Inc. | Initial registration statement for securities to be of... | 05/14/2026 | ||
| 4 | Juhas Peter | Statement of changes in beneficial ownership of securi... | Aercap Holdings N.v. | 05/13/2026 | |
| 6-K | British American Tobacco P.l.c. | Current report of foreign issuer pursuant to Rules 13a... | 05/13/2026 | ||
| 4 | Bank Of Nova Scotia | Statement of changes in beneficial ownership of securi... | Keycorp /new/ | 05/12/2026 | |
| 4 | Bank Of Nova Scotia | Statement of changes in beneficial ownership of securi... | Keycorp /new/ | 05/12/2026 | |
| SC TO-T/A | Biogen Inc. | Amendment to Third party tender offer statement | Apellis Pharmaceuticals, Inc. | 05/12/2026 | |
| SC TO-T/A | Biogen Inc. | Amendment to Third party tender offer statement | Apellis Pharmaceuticals, Inc. | 05/12/2026 | |
| 144 | Aercap Holdings N.v. | Filing for proposed sale of securities under Rule 144 | 05/11/2026 | ||
| Load More | |||||
